On May 16, riders from across the globe will descend on Nevada City, California for the opening stage of the 2010 Amgen Tour of California. Team Type 1 will bring a powerful lineup to the race to compete against the deepest field the eight-stage race has assembled in its five-year history.
Javier Megias, a rider with Type 1 diabetes will be joined by general classification hopefuls Davide Frattini and Valeriy Kobzarenko, sprint specialists Ken Hanson and Aldo Ilesic, and stage hunters Chris Jones, Thomas Rabou and Scott Stewart.
“Team Type 1’s goal is to be as aggressive as possible and aim for a stage win,” said Director Sportif, Vassili Davidenko. We have our eyes on the King of the Mountain jersey, and will aim to gain the best possible place in general classification. We have a crew built for speed, but we should also be strong on the climbs.”
The Amgen Tour of California will get underway on Sunday, May 16th, and concludes on Sunday, May 23rd. An internationally sanctioned, professional cycling road race, the 2010 Amgen Tour of California will host 16 teams, comprised of 127 riders, from 23 countries for the fifth-annual race.
The 2010 Amgen Tour of California will bring an exceptional concentration of cycling talent to compete across more than 800 miles of the state of California from Nevada City to Thousand Oaks. Attracting an unprecedented field of riders from around the world, from Lance Armstrong to Mark Cavendish, cyclists hail from countries as far away as Belgium, Finland, Spain, France, Germany, New Zealand and Sweden.
“It is a true privilege to be invited to participate in the Amgen Tour of California,” notes Team Type 1 co-founder and CEO, Phil Southerland. “This is the greatest race in the history of American cycling and to have a rider [Javier Megias] with Type 1 diabetes in the peloton with some of the greatest cyclists of all time is proof that it is possible to achieve one’s dreams when one controls their diabetes properly.”
Team Type 1 has made every preparation and fine tuned every aspect of their spring in preparation for the 2010 Amgen Tour of California, and have given themselves the best chance possible at success over the tour’s eight days of racing.